Quarterly report · Q3

Period2023-04-01 → 2023-12-31
Filed2024-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥10.6bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥13.8bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥9.8bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥1.4bn2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥1.3bn2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥1.5bn2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥1.8bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.3bn2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥1.5bn2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥1.3bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥995m2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.3bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥873m2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥1.0bn2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥879m2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥22.0bnat 2023-12-31Cons.Assets
Total assets¥21.2bnat 2023-03-31Cons.Assets
Total assets¥20.5bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥5.3bnat 2023-12-31Cons.Liabilities
Total liabilities¥5.7bnat 2023-03-31Cons.Liabilities
Net assets / equity¥16.7bnat 2023-12-31Cons.Net assets
Net assets / equity¥15.6bnat 2023-03-31Cons.Net assets
Net assets / equity¥15.1bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥9.0bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥9.0bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥319.192023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥120.032023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥402.982022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥280.542022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥100.512022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio74.7%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio72.3%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio72.8%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 54
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-12-31¥773m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-12-31¥773m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-12-31¥116m
jpcrp040300-q3r_E03330-000Care Welfare Relatedreportable segmentrevenue2023-04-01 → 2023-12-31¥887m
jpcrp040300-q3r_E03330-000Care Welfare Relatedreportable segmentrevenue external2023-04-01 → 2023-12-31¥887m
jpcrp040300-q3r_E03330-000Care Welfare Relatedreportable segmentsegment profit2023-04-01 → 2023-12-31¥29m
jpcrp040300-q3r_E03330-000Home Medical Treatment Relatedreportable segmentrevenue2023-04-01 → 2023-12-31¥4.7bn
jpcrp040300-q3r_E03330-000Home Medical Treatment Relatedreportable segmentrevenue external2023-04-01 → 2023-12-31¥4.7bn
jpcrp040300-q3r_E03330-000Home Medical Treatment Relatedreportable segmentsegment profit2023-04-01 → 2023-12-31¥591m
jpcrp040300-q3r_E03330-000Medical Gas Equipment Installation Relatedreportable segmentrevenue2023-04-01 → 2023-12-31¥1.3bn
jpcrp040300-q3r_E03330-000Medical Gas Equipment Installation Relatedreportable segmentrevenue external2023-04-01 → 2023-12-31¥1.2bn
jpcrp040300-q3r_E03330-000Medical Gas Equipment Installation Relatedreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥72m
jpcrp040300-q3r_E03330-000Medical Gas Equipment Installation Relatedreportable segmentsegment profit2023-04-01 → 2023-12-31¥223m
jpcrp040300-q3r_E03330-000Medical Gas Relatedreportable segmentrevenue2023-04-01 → 2023-12-31¥2.8bn
jpcrp040300-q3r_E03330-000Medical Gas Relatedreportable segmentrevenue external2023-04-01 → 2023-12-31¥2.8bn
jpcrp040300-q3r_E03330-000Medical Gas Relatedreportable segmentsegment profit2023-04-01 → 2023-12-31¥421m
jpcrp040300-q3r_E03330-000Nursing Homereportable segmentrevenue2023-04-01 → 2023-12-31¥263m
jpcrp040300-q3r_E03330-000Nursing Homereportable segmentrevenue external2023-04-01 → 2023-12-31¥263m
jpcrp040300-q3r_E03330-000Nursing Homereportable segmentsegment profit2023-04-01 → 2023-12-31¥16m
—segment totalrevenue2023-04-01 → 2023-12-31¥9.9bn
—segment totalrevenue external2023-04-01 → 2023-12-31¥9.9bn
—segment totalrevenue intersegment2023-04-01 → 2023-12-31¥72m
—segment totalsegment profit2023-04-01 → 2023-12-31¥1.3bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-12-31¥10.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-12-31¥10.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-12-31¥72m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-12-31¥1.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-12-31¥825m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-12-31¥825m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-12-31¥123m
jpcrp040300-q3r_E03330-000Care Welfare Relatedreportable segmentrevenue2022-04-01 → 2022-12-31¥683m
jpcrp040300-q3r_E03330-000Care Welfare Relatedreportable segmentrevenue external2022-04-01 → 2022-12-31¥683m
jpcrp040300-q3r_E03330-000Care Welfare Relatedreportable segmentsegment profit2022-04-01 → 2022-12-31¥3m
jpcrp040300-q3r_E03330-000Home Medical Treatment Relatedreportable segmentrevenue2022-04-01 → 2022-12-31¥4.4bn
jpcrp040300-q3r_E03330-000Home Medical Treatment Relatedreportable segmentrevenue external2022-04-01 → 2022-12-31¥4.4bn
jpcrp040300-q3r_E03330-000Home Medical Treatment Relatedreportable segmentsegment profit2022-04-01 → 2022-12-31¥599m
jpcrp040300-q3r_E03330-000Medical Gas Equipment Installation Relatedreportable segmentrevenue2022-04-01 → 2022-12-31¥1.0bn
jpcrp040300-q3r_E03330-000Medical Gas Equipment Installation Relatedreportable segmentrevenue external2022-04-01 → 2022-12-31¥932m
jpcrp040300-q3r_E03330-000Medical Gas Equipment Installation Relatedreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥71m
jpcrp040300-q3r_E03330-000Medical Gas Equipment Installation Relatedreportable segmentsegment profit2022-04-01 → 2022-12-31¥174m
jpcrp040300-q3r_E03330-000Medical Gas Relatedreportable segmentrevenue2022-04-01 → 2022-12-31¥2.7bn
jpcrp040300-q3r_E03330-000Medical Gas Relatedreportable segmentrevenue external2022-04-01 → 2022-12-31¥2.7bn
jpcrp040300-q3r_E03330-000Medical Gas Relatedreportable segmentsegment profit2022-04-01 → 2022-12-31¥336m
jpcrp040300-q3r_E03330-000Nursing Homereportable segmentrevenue2022-04-01 → 2022-12-31¥267m
jpcrp040300-q3r_E03330-000Nursing Homereportable segmentrevenue external2022-04-01 → 2022-12-31¥267m
jpcrp040300-q3r_E03330-000Nursing Homereportable segmentsegment profit2022-04-01 → 2022-12-31¥23m
—segment totalrevenue2022-04-01 → 2022-12-31¥9.1bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥9.0bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥71m
—segment totalsegment profit2022-04-01 → 2022-12-31¥1.1bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥9.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥9.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥71m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥1.3bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 356
ItemContextValueUnit
End date of quarterly or semi annual period of next fiscal yearFilingDateInstant-
Amendment flagFilingDateInstantfalse
Identification of document subject to amendmentFilingDateInstant-
Report amendment flagFilingDateInstantfalse
Xbrl amendment flagFilingDateInstantfalse
Business results of group (text)FilingDateInstantText · Plus
Description of business (text)FilingDateInstantText · Plus
Business risks (text)FilingDateInstantText · Plus
Management analysis of financial position operating results and cash flows (text)FilingDateInstantText · Plus
Critical contracts for operation (text)FilingDateInstantText · Plus
Total number of shares (text)FilingDateInstantText · Plus
Issued shares total number of shares etc (text)FilingDateInstantText · Plus
Class issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember
Original text (Japanese)普通株式
Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registeredFilingDateInstant_OrdinaryShareMember
Original text (Japanese)東京証券取引所スタンダード市場
Description issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember
Original text (Japanese)株主としての権利内容に制限のない、標準となる株式であり、単元株式数は100株であります。
Details of employee share option program (text)FilingDateInstantText · Plus
Other information on share acquisition rights (text)FilingDateInstantText · Plus
Exercises etc of moving strike convertible bonds etc (text)FilingDateInstantText · Plus
Changes in number of issued shares stated capital etc (text)FilingDateInstantText · Plus
Major shareholders (text)FilingDateInstantText · Plus
Issued shares voting rights (text)FilingDateInstantText · Plus
Description issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Description issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Description issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Description issued shares voting rightsCurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember
Original text (Japanese)株主としての権利内容に制限のない、標準となる株式
Description issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember
Original text (Japanese)同上
Description issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember
Original text (Japanese)同上
Treasury shares etc (text)FilingDateInstantText · Plus
Name of shareholder treasury shares etcCurrentQuarterInstant_Row1Member
Original text (Japanese)株式会社星医療酸器
Address of shareholder treasury shares etcCurrentQuarterInstant_Row1Member
Original text (Japanese)東京都足立区入谷七丁目11番18号
Information about officers (text)FilingDateInstantText · Plus
Regulations in accordance with which consolidated financial statements have been prepared financial informationCurrentYTDDurationText · Plus
Note on independent audit financial informationCurrentYTDDurationText · Plus
Quarterly consolidated balance sheet (text)CurrentYTDDurationText · Plus
Year to quarter end consolidated statement of income (text)CurrentYTDDurationText · Plus
Year to quarter end consolidated statement of comprehensive income (text)CurrentYTDDurationText · Plus
Notes uncertainties of entitys ability to continue as going concern quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Notes changes in scope of consolidation or equity method (text)CurrentYTDDurationText · Plus
Notes accounting treatments specific to quarterly financial statements quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Description of fact that quarterly statement of cash flows has not been prepared (text)CurrentYTDDurationText · Plus
Notes regarding dividend (text)Prior1YTDDurationText · Plus
Notes when there is significant changes in amounts of equity (text)Prior1YTDDurationText · Plus
Notes regarding dividend (text)CurrentYTDDurationText · Plus
Notes when there is significant changes in amounts of equity (text)CurrentYTDDurationText · Plus
Notes segment information etc quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Footnotes regarding segment information table (text)Prior1YTDDurationText · Plus
Description of nature of differences between profit loss of reportable segments total and quarterly financial statements (text)Prior1YTDDurationText · Plus
Information about impairment loss of non current assets or goodwill etc for each reportable segment (text)Prior1YTDDurationText · Plus
Footnotes regarding segment information table (text)CurrentYTDDurationText · Plus
Description of nature of differences between profit loss of reportable segments total and quarterly financial statements (text)CurrentYTDDurationText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass